Citigroup Inc Cortexyme, Inc. Transaction History

Citigroup Inc

  • $169 Billion
  • Q3 2024

A detailed history of Citigroup Inc transactions in Cortexyme, Inc. stock. As of the latest transaction made, Citigroup Inc holds 17,127 shares of CRTX stock, worth $22,093. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,127
Previous 5,165 231.6%
Holding current value
$22,093
Previous $6,000 266.67%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
N/A
11,962 Added 231.6%
17,127 $22,000
Q4 2022

Feb 09, 2023
SELL
N/A
-391 Reduced 7.04%
5,165 $6,000
Q3 2022

Nov 10, 2022
SELL
$1.29 - $2.52 $393 - $768
-305 Reduced 5.2%
5,556 $7,000
Q2 2022

Aug 10, 2022
SELL
$2.22 - $6.7 $6,329 - $19,101
-2,851 Reduced 32.72%
5,861 $13,000
Q1 2022

May 12, 2022
SELL
$4.18 - $13.39 $32,307 - $103,491
-7,729 Reduced 47.01%
8,712 $54,000
Q4 2021

Feb 10, 2022
SELL
$11.35 - $97.17 $446,838 - $3.83 Million
-39,369 Reduced 70.54%
16,441 $207,000
Q3 2021

Nov 10, 2021
BUY
$52.0 - $120.21 $2.9 Million - $6.71 Million
55,810 New
55,810 $5.12 Million

Others Institutions Holding CRTX

# of Institutions
39
Shares Held
5.21M
Call Options Held
90.8K
Put Options Held
0
View Full List

About Cortexyme, Inc.

CRTX Quotes by TradingView
  • Ticker CRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,150,800
  • Market Cap $70.5M
More about CRTX
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email